triamterene has been researched along with Hypertension, Malignant in 2 studies
Triamterene: A pteridinetriamine compound that inhibits SODIUM reabsorption through SODIUM CHANNELS in renal EPITHELIAL CELLS.
triamterene : Pteridine substituted at positions 2, 4 and 7 with amino groups and at position 6 with a phenyl group. A sodium channel blocker, it is used as a diuretic in the treatment of hypertension and oedema.
Hypertension, Malignant: A condition of markedly elevated BLOOD PRESSURE with DIASTOLIC PRESSURE usually greater than 120 mm Hg. Malignant hypertension is characterized by widespread vascular damage, PAPILLEDEMA, retinopathy, HYPERTENSIVE ENCEPHALOPATHY, and renal dysfunction.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 2 (100.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
SINGER, MM | 1 |
HOFF, HR | 1 |
FISCH, S | 1 |
DEGRAFF, AC | 1 |
Hagino, K | 1 |
2 other studies available for triamterene and Hypertension, Malignant
Article | Year |
---|---|
RED BLOOD CELL POTASSIUM; THERAPEUTIC IMPLICATIONS.
Topics: Anemia; Anemia, Hypochromic; Blood Platelets; Digitalis Glycosides; Diuretics; Erythrocytes; Fludroc | 1964 |
[Hypertension--malignant hypertension].
Topics: Diuretics; Hexamethonium Compounds; Humans; Hydrazines; Hypertension, Malignant; Male; Methyldopa; M | 1971 |